Life Sciences Commons^™

Identifying Senescence As A Mode Of Chemo Resistance In Ovarian Cancer, Noelle L. Cutter Ph.D., Jennifer Furman, Ryan Frank, Cassandra Greco, Matthrew Lucito

Faculty Works: Biology, Chemistry, and Environmental Studies

Current treatments of ovarian and breast cancer result in chemo resistance all too often. It has been hypothesized that senescence-a dormant condition associated with increased age and apoptosis- may play a role in the development of chemo resistance. We performed an in-vitro study with HOSE (carboplatin-sensitive), SKOV3 (chemo resistant ovarian cancer), and CAMA1 (chemo resistant breast cancer) cell lines, which were exposed to a variety of platinum-based treatments meant to model current cover clinically relevant scenarios in terms of tumor hypoxia. They were then stained for senescence in-vitro using B-gal, and analyzed for proliferation using the Cell Counting Kit 8, …